NCT07228611 Assesment and Comparison of Osteoporosis Risk Factors After Stroke
| NCT ID | NCT07228611 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Stroke Osteoporosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-12-05 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 84 participants in total. It began in 2025-12-05 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.
Eligibility Criteria
Inclusion Criteria: 1. Followed by ischemic or hemorrhagic stroke 2. Between 1 week and 6 months or \>1 year has passed since the date of the event 3. Being between 55 and 85 years of age Exclusion Criteria: 1. The patient has additional neurological conditions besides stroke 2. The patient has a psychiatric condition 3. History of recurrent stroke 4. BMD scan performed within the last year for stroke patients 5. Having received osteoporosis treatment before or after the stroke 6. The patient having a fragility fracture before the stroke 7. The patient having a hip fracture or hip prosthesis 8. The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture) 9. The patient has an additional disease or medication use that could cause secondary osteoporosis 10. The patient's stroke did not cause physical function loss
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07228611 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 85 Years, studying Stroke Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07228611 currently recruiting?
Yes, NCT07228611 is actively recruiting participants. Contact the research team at kalemnaz@gmail.com for enrollment information.
Where is the NCT07228611 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07228611 clinical trial?
NCT07228611 is sponsored by Ankara Etlik City Hospital. The trial plans to enroll 84 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.